BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24899083)

  • 1. The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer.
    Sabatino SA; Thompson TD; Wu XC; Fleming ST; Kimmick GG; Trentham-Dietz A; Cress R; Anderson RT
    Breast Cancer Res Treat; 2014 Jul; 146(1):199-209. PubMed ID: 24899083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidity burden and guideline-concordant care for breast cancer.
    Kimmick G; Fleming ST; Sabatino SA; Wu XC; Hwang W; Wilson JF; Lund MJ; Cress R; Anderson RT;
    J Am Geriatr Soc; 2014 Mar; 62(3):482-8. PubMed ID: 24512124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancer.
    Kimmick GG; Li X; Fleming ST; Sabatino SA; Wilson JF; Lipscomb J; Cress R; Bergom C; Anderson RT; Wu XC;
    J Geriatr Oncol; 2018 May; 9(3):214-220. PubMed ID: 29174187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Diabetes and Other Clinical and Sociodemographic Factors With Guideline-concordant Breast Cancer Treatment for Breast Cancer.
    Gold HT; Shao H; Oratz R; Yu O; Hammer M; Richardson S; Boudreau D
    Am J Clin Oncol; 2020 Feb; 43(2):101-106. PubMed ID: 31850918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-Based Study on Cancer Subtypes, Guideline-Concordant Adjuvant Therapy, and Survival Among Women With Stage I-III Breast Cancer.
    Hsieh MC; Zhang L; Wu XC; Davidson MB; Loch M; Chen VW
    J Natl Compr Canc Netw; 2019 Jun; 17(6):676-686. PubMed ID: 31200362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guideline-Concordant Treatment Among Elderly Women With HER2-Positive Metastatic Breast Cancer in the United States.
    Vyas AM; Aroke H; Kogut S
    J Natl Compr Canc Netw; 2020 Apr; 18(4):405-413. PubMed ID: 32259787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.
    Wu XC; Lund MJ; Kimmick GG; Richardson LC; Sabatino SA; Chen VW; Fleming ST; Morris CR; Huang B; Trentham-Dietz A; Lipscomb J
    J Clin Oncol; 2012 Jan; 30(2):142-50. PubMed ID: 22147735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Diabetes on Breast Cancer Treatments and Outcomes: A Population-Based Study.
    Lega IC; Austin PC; Fischer HD; Fung K; Krzyzanowska MK; Amir E; Lipscombe LL
    Diabetes Care; 2018 Apr; 41(4):755-761. PubMed ID: 29351960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guideline-concordant treatment predicts survival: a National Cancer Database validation study of novel composite locoregional and systemic treatment scores among women with early stage breast cancer.
    Yen TWF; Garacci Z; Laud PW; Pezzin LE; Nattinger AB
    Breast Cancer; 2021 May; 28(3):698-709. PubMed ID: 33398775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.
    Fang P; He W; Gomez DR; Hoffman KE; Smith BD; Giordano SH; Jagsi R; Smith GL
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):748-757. PubMed ID: 28366580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receipt of Guideline-Concordant Care Among Older Women With Stage I-III Breast Cancer: A Population-Based Study.
    LeMasters T; Madhavan SS; Sambamoorthi U; Hazard-Jenkins HW; Kelly KM; Long D
    J Natl Compr Canc Netw; 2018 Jun; 16(6):703-710. PubMed ID: 29891521
    [No Abstract]   [Full Text] [Related]  

  • 12. Variations in Guideline-Concordant Breast Cancer Adjuvant Therapy in Rural Georgia.
    Guy GP; Lipscomb J; Gillespie TW; Goodman M; Richardson LC; Ward KC
    Health Serv Res; 2015 Aug; 50(4):1088-108. PubMed ID: 25491350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of locoregional treatment for nonmetastatic breast cancer by patient and health system factors.
    Anderson RT; Morris CR; Kimmick G; Trentham-Dietz A; Camacho F; Wu XC; Sabatino SA; Fleming ST; Lipscomb J
    Cancer; 2015 Mar; 121(5):790-9. PubMed ID: 25369150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of comorbid conditions and early-stage breast cancer therapy: linked SEER-Medicare data from 1993 to 2005.
    Yasmeen S; Chlebowski RT; Xing G; Morris CR; Romano PS
    Cancer Med; 2013 Aug; 2(4):526-36. PubMed ID: 24156025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-clinician interactions and disparities in breast cancer care: the equality in breast cancer care study.
    Gonzales FA; Sangaramoorthy M; Dwyer LA; Shariff-Marco S; Allen AM; Kurian AW; Yang J; Langer MM; Allen L; Reeve BB; Taplin SH; Gomez SL
    J Cancer Surviv; 2019 Dec; 13(6):968-980. PubMed ID: 31646462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer treatment guidelines in older women.
    Giordano SH; Hortobagyi GN; Kau SW; Theriault RL; Bondy ML
    J Clin Oncol; 2005 Feb; 23(4):783-91. PubMed ID: 15681522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients.
    Hsieh MC; Thompson T; Wu XC; Styles T; O'Flarity MB; Morris CR; Chen VW
    Cancer Med; 2016 May; 5(5):871-80. PubMed ID: 26773804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Impact of 21-Gene Recurrence Score Test Within the Veterans Health Administration: Utilization and Receipt of Guideline-Concordant Care.
    Hull LE; Lynch JA; Berse BB; DuVall SL; Chun DS; Venne VL; Efimova OV; Icardi MS; Kelley MJ
    Clin Breast Cancer; 2018 Apr; 18(2):135-143. PubMed ID: 29306660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual, Area, and Provider Characteristics Associated With Care Received for Stages I to III Breast Cancer in a Multistate Region of Appalachia.
    Kimmick GG; Camacho F; Mackley HB; Kern T; Yao N; Matthews SA; Fleming S; Lipscomb J; Liao J; Hwang W; Anderson RT
    J Oncol Pract; 2015 Jan; 11(1):e9-e18. PubMed ID: 25228530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors.
    Lakkad M; Martin B; Li C; Harrington S; Dayer L; Painter JT
    Clin Breast Cancer; 2023 Aug; 23(6):598-619. PubMed ID: 37328334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.